Have a feature idea you'd love to see implemented? Let us know!

PROK ProKidney Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PROK

Price (delayed)

$1.58

Market cap

$460.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.55

Enterprise value

$359.18M

Highlights
ProKidney's equity has increased by 10% YoY
The EPS has increased by 7% since the previous quarter and by 5% year-on-year
ProKidney's debt has soared by 131% YoY but it has decreased by 3.5% from the previous quarter
The net income has declined by 26% year-on-year and by 18% since the previous quarter
PROK's quick ratio is down by 23% QoQ and by 14% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER OMGA ONVO

Key stats

What are the main financial stats of PROK
Market
Shares outstanding
291.66M
Market cap
$460.83M
Enterprise value
$359.18M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Net income
-$45.61M
EBIT
-$45.11M
EBITDA
-$40.1M
Free cash flow
-$133.14M
Per share
EPS
-$0.55
EPS diluted
-$0.55
Free cash flow per share
-$1.06
Book value per share
-$3.38
Revenue per share
$0
TBVPS
$3.76
Balance sheet
Total assets
$474.79M
Total liabilities
$31.33M
Debt
$6.44M
Equity
-$979.71M
Working capital
$405.04M
Liquidity
Debt to equity
-0.01
Current ratio
17.09
Quick ratio
16.16
Net debt/EBITDA
2.53
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-10.2%
Return on equity
N/A
Return on invested capital
-14.5%
Return on capital employed
-10%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PROK stock price

How has the ProKidney stock price performed over time
Intraday
-4.24%
1 week
-13.66%
1 month
-11.98%
1 year
-1.86%
YTD
-6.51%
QTD
-6.51%

Financial performance

How have ProKidney's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$156.32M
Net income
-$45.61M
Gross margin
N/A
Net margin
N/A
The net income has declined by 26% year-on-year and by 18% since the previous quarter

Growth

What is ProKidney's growth rate over time

Valuation

What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 7% since the previous quarter and by 5% year-on-year
ProKidney's equity has increased by 10% YoY

Efficiency

How efficient is ProKidney business performance
The return on assets has declined by 38% year-on-year and by 16% since the previous quarter
The return on invested capital rose by 26% year-on-year but it has declined by 19% since the previous quarter

Dividends

What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PROK.

Financial health

How did ProKidney financials performed over time
ProKidney's total liabilities has increased by 33% YoY and by 17% QoQ
PROK's quick ratio is down by 23% QoQ and by 14% YoY
ProKidney's debt is 101% more than its equity
ProKidney's debt has soared by 131% YoY but it has decreased by 3.5% from the previous quarter
ProKidney's equity has increased by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.